ID: ALA4853696

Max Phase: Preclinical

Molecular Formula: C42H53N9O6

Molecular Weight: 779.94

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(C)c1cnn2c(NCc3ccc(NC(=O)CCCCCCCOc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)cc3)nc(OC3CCN(C)CC3)nc12

Standard InChI:  InChI=1S/C42H53N9O6/c1-27(2)32-25-44-51-38(32)47-42(57-30-19-21-49(3)22-20-30)48-41(51)43-24-28-13-15-29(16-14-28)45-36(52)12-7-5-4-6-8-23-56-35-11-9-10-31-33(35)26-50(40(31)55)34-17-18-37(53)46-39(34)54/h9-11,13-16,25,27,30,34H,4-8,12,17-24,26H2,1-3H3,(H,45,52)(H,43,47,48)(H,46,53,54)

Standard InChI Key:  WFRJZAATGZSBLF-UHFFFAOYSA-N

Associated Targets(Human)

MDA-MB-468 9477 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BT-549 31254 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein cereblon/CDK9 113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 779.94Molecular Weight (Monoisotopic): 779.4119AlogP: 5.45#Rotatable Bonds: 17
Polar Surface Area: 172.39Molecular Species: NEUTRALHBA: 12HBD: 3
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.61CX Basic pKa: 8.22CX LogP: 4.85CX LogD: 3.96
Aromatic Rings: 4Heavy Atoms: 57QED Weighted: 0.09Np Likeness Score: -0.67

References

1. Wei D, Wang H, Zeng Q, Wang W, Hao B, Feng X, Wang P, Song N, Kan W, Huang G, Zhou X, Tan M, Zhou Y, Huang R, Li J, Chen XH..  (2021)  Discovery of Potent and Selective CDK9 Degraders for Targeting Transcription Regulation in Triple-Negative Breast Cancer.,  64  (19.0): [PMID:34538051] [10.1021/acs.jmedchem.1c01350]

Source